London Daily

Focus on the big picture.
Thursday, Sep 25, 2025

State-funded UK study says Pfizer, AstraZeneca vaccines are ‘highly effective’ against Indian Covid-19 variant

State-funded UK study says Pfizer, AstraZeneca vaccines are ‘highly effective’ against Indian Covid-19 variant

Two doses of the Pfizer and AstraZeneca vaccines provide sufficient protection against symptomatic disease from the Indian strain of Covid-19, which is thought to be more vaccine-resistant, a study by Public Health England says.
“New study by PHE shows for the first time that 2 doses of the COVID-19 vaccines are highly effective” against the virus variant first identified in India, a UK government press release citing the study’s results said.

The research shows that the Pfizer vaccine provides 88% protection against symptomatic disease caused by the Indian variant two weeks after the patient receives the second dose, while AstraZeneca’s vaccine is 66% effective.

The first dose of both vaccines is only 33% effective against symptomatic disease. The press release explains the difference in the effectiveness of the two by the fact that the “rollout of second doses of AstraZeneca was later than for the Pfizer-BioNTech vaccine,” and it “takes longer to reach maximum effectiveness with the AstraZeneca.”

“This study provides reassurance that 2 doses of either vaccine offer high levels of protection against symptomatic disease from the [Indian] variant,” Dr. Mary Ramsay, the head of immunisation at Public Health England (PHE), said.

She also said the researchers expect the vaccines to be “even more effective at preventing hospitalisation and death,” though they do not have sufficient evidence to estimate the effectiveness against severe outcomes of infections caused by the Indian strain, the government statement said.

Despite providing a decent level of protection after two doses, both vaccines appear to be slightly less effective against the Indian variant in comparison to the British strain, the study shows. According to PHE, Pfizer is 93% effective against the British strain, and AstraZeneca provides 66% protection after two doses.

The results were lauded by Health Secretary Matt Hancock, who called them groundbreaking evidence in support of the UK’s vaccination program.

“We can now be confident that over 20 million people – more than 1 in 3 – have significant protection against this new variant, and that number is growing by the hundreds of thousands every single day as more and more people get that vital second dose,” he said.

The study was based on an analysis of 1,054 cases in which people in the UK contracted the Indian virus variant between early April and mid-May.

The results came just days after Germany’s public health agency, the Robert Koch Institute, warned that the existing vaccines could be less effective against the Indian variant. Germany also said it was reassessing its travel arrangements with the UK after a small number of cases of the new mutation were detected in Britain.

First discovered in India in October 2020, the so-called ‘Indian strain’ has since spread to more than 50 countries worldwide and was declared a “variant of concern” by the World Health Organization (WHO) due to fears it could be more transmissible and more resistant to vaccines and treatment.

The UK has reported the most cases linked to the Indian strain among all European countries – more than 3,850 were reported as of May 19.
Newsletter

Related Articles

0:00
0:00
Close
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
Nvidia and Abu Dhabi’s TII Launch First AI-&-Robotics Lab in the Middle East
Vietnam Faces Up to $25 Billion Export Loss as U.S. Tariffs Bite
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Indonesia Court Upholds Military Law Amid Concerns Over Expanded Civilian Role
Larry Ellison, Michael Dell and Rupert Murdoch Join Trump-Backed Bid to Take Over TikTok
Trump and Musk Reunite Publicly for First Time Since Fallout at Kirk Memorial
Vietnam Closes 86 Million Untouched Bank Accounts Over Biometric ID Rules
Explosive Email Shows Sarah Ferguson Begged Forgiveness from Jeffrey Epstein After Taking His Money
Corrupt UK Politician Ed Davey Demands Elon Musk’s Arrest for Supporting Democracy
UK, Canada, and Australia Officially Recognise Palestine in Historic Shift
Alibaba Debuts Open-Source Deep Research Agent with Benchmarks Rivaling OpenAI
Marcos Faces Legacy-Defining Crisis as Flood Projects Scandal Sparks Massive Tide of Protests
China’s Micro-Drama Boom Turns Stalled Real Estate Projects into Lavish Film Sets
New Eye Drops Show Promise in Replacing Reading Glasses for Presbyopia
'Company Got 5,189 H-1B Visas, Then Laid Off 16,000 Americans': US Defends New $100,000 H-1B Visa Fee
Golf legend tells Omar she should be 'sent back to Somalia' after her Kirk comments
EU Set to Bar Big Tech from New Financial Data Access Scheme
China Bans Livestreaming and AI in Religion Amid Crackdown on Shaolin Temple Scandal
Documents Reveal Mandelson Failed to Declare Epstein-Funded Flights as MP in 2003
Dubai Property Boom Shows Strain as Flippers Get Buyer’s Remorse
Harris Memoir Sparks Backlash from Democrats for Blunt Critiques in ‘107 Days’
Germany Weighs Excluding France from Key European Fighter Jet Programme
Cyberattack Disrupts Check-in and Boarding Systems at Major European Airports
Japan’s ‘Death-Tainted’ Homes Gain Appeal as Prices Soar in Tokyo
Massive Attack Withdraws from Spotify Over Daniel Ek’s €600M Defence-AI Investment
Björn Borg Breaks Silence: Memoir Reveals Addiction, Shame and Cancer Battle
When Extremism Hijacks Idealism: How the Baader-Meinhof Gang Emerged and Fell
Top AI Researchers Are Heading Back to China as U.S. Struggles to Keep Pace
JWST Data Brings TRAPPIST-1e Closer to Earth-Like Habitability
Trump Orders Third Lethal Strike on Drug-Trafficking Vessel as U.S. Expands Maritime Counter-Narcotics Operations
Trump Orders $100,000 Fee on H-1B Visas and Launches ‘Gold Card’ Immigration Pathway
Why Google Search Is Fading and AI Is Taking Its Place
×